Alcohol-related changes in the intestinal microbiome influence neutrophil infiltration, inflammation and steatosis in early alcoholic hepatitis in mice.

BACKGROUND:Alcohol-induced intestinal dysbiosis disrupts homeostatic gut-liver axis function and is essential in the development of alcoholic liver disease. Here, we investigate changes in enteric microbiome composition in a model of early alcoholic steatohepatitis and dissect the pathogenic role of...

Full description

Bibliographic Details
Published in:	PLoS ONE
Main Authors:	Patrick P Lowe, Benedek Gyongyosi, Abhishek Satishchandran, Arvin Iracheta-Vellve, Aditya Ambade, Karen Kodys, Donna Catalano, Doyle V Ward, Gyongyi Szabo
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2017-01-01
Online Access:	http://europepmc.org/articles/PMC5370121?pdf=render

Similar Items

Correction: Alcohol-related changes in the intestinal microbiome influence neutrophil infiltration, inflammation and steatosis in early alcoholic hepatitis in mice.
by: Patrick P Lowe, et al.
Published: (2017-01-01)

Reduced gut microbiome protects from alcohol-induced neuroinflammation and alters intestinal and brain inflammasome expression
by: Patrick P. Lowe, et al.
Published: (2018-10-01)

MicroRNA-155 Deficiency Attenuates Liver Steatosis and Fibrosis without Reducing Inflammation in a Mouse Model of Steatohepatitis.
by: Timea Csak, et al.
Published: (2015-01-01)

Granulocyte colony‐stimulating factor attenuates liver damage by M2 macrophage polarization and hepatocyte proliferation in alcoholic hepatitis in mice
by: Yeonhee Cho, et al.
Published: (2022-09-01)

Alcohol and Steatosis: The Japanese Paradox
by: A. Lonardo, et al.
Published: (2016-06-01)

Oxidative Stress and Inflammation: Essential Partners in Alcoholic Liver Disease
by: Aditya Ambade, et al.
Published: (2012-01-01)

MicroRNA Signature in Alcoholic Liver Disease
by: Shashi Bala, et al.
Published: (2012-01-01)

Innate immune activation: Parallels in alcohol use disorder and Alzheimer’s disease
by: Adriana Ramos, et al.
Published: (2022-09-01)

Targeting Epigenetic Mechanisms to Alleviate Alcoholic Steatosis
by: Pranoti Mandrekar, PhD
Published: (2020-01-01)

Toll-Like Receptors in the Pathogenesis of Alcoholic Liver Disease
by: Jan Petrasek, et al.
Published: (2010-01-01)

Clinical Presentation and Gene Expression of Acute Alcohol‐Induced Microvesicular Steatosis Mimicking Alcoholic Hepatitis
by: Laurent Spahr, et al.
Published: (2021-04-01)

RIPK3-Mediated Necroptosis and Neutrophil Infiltration Are Associated with Poor Prognosis in Patients with Alcoholic Cirrhosis
by: Zhenzhen Zhang, et al.
Published: (2018-01-01)

P-57 LIVER STEATOSIS AND STEATOHEPATITIS IN LIVER DISEASES OTHER THAN ALCOHOLIC AND NON-ALCOHOLIC FATTY LIVER
by: Ana Jiménez, et al.
Published: (2021-09-01)

Alcohol Abstinence Rescues Hepatic Steatosis and Liver Injury via Improving Metabolic Reprogramming in Chronic Alcohol-Fed Mice
by: Aiwen Pi, et al.
Published: (2021-09-01)

Corrigendum: Alcohol abstinence rescues hepatic steatosis and liver injury via improving metabolic reprogramming in chronic alcohol-fed mice
by: Aiwen Pi, et al.
Published: (2025-02-01)

The relationship between changes in alcohol consumption and hepatic steatosis among alcohol consumers: a large-scale population-based Biobank study
by: Suosu Wei, et al.
Published: (2025-10-01)

Continuum of non-alcoholic fatty liver disease: from hepatic steatosis to cardiovascular risk
by: O. M. Drapkina, et al.
Published: (2016-09-01)

Recovery of Bacteroides thetaiotaomicron ameliorates hepatic steatosis in experimental alcohol-related liver disease
by: Moris Sangineto, et al.
Published: (2022-12-01)

Sympathetic overdrive and unrestrained adipose lipolysis drive alcohol-induced hepatic steatosis in rodents
by: Chunxue Zhou, et al.
Published: (2023-12-01)

Characterization of an alcoholic hepatic steatosis model induced by ethanol and high-fat diet in rats
by: Carlos Eduardo Alves de Souza, et al.
Published: (2015-06-01)

CD36-deficient mice are resistant to alcohol- and high-carbohydrate-induced hepatic steatosis[S]
by: Robin D. Clugston, et al.
Published: (2014-02-01)

Combined Insults of a MASH Diet and Alcohol Binges Activate Intercellular Communication and Neutrophil Recruitment via the NLRP3-IL-1β Axis in the Liver
by: Mrigya Babuta, et al.
Published: (2024-06-01)

G-CSF increases calprotectin expression, liver damage and neuroinflammation in a murine model of alcohol-induced ACLF
by: Martí Ortega-Ribera, et al.
Published: (2024-02-01)

Transgenic overexpression of CTRP3 does not prevent alcohol induced hepatic steatosis in female mice.
by: Kristy L Thomas, et al.
Published: (2022-01-01)

Pharmacological inhibition of p300 ameliorates steatosis, inflammation, and fibrosis in mice with non-alcoholic steatohepatitis
by: Jung-Yeon Kim, et al.
Published: (2024-05-01)

Pancreatic steatosis and iron overload increases cardiovascular risk in non-alcoholic fatty liver disease
by: David Marti-Aguado, et al.
Published: (2023-08-01)

Inhibition of phospholipase D1 ameliorates hepatocyte steatosis and non-alcoholic fatty liver disease
by: Huan Wang, et al.
Published: (2023-06-01)

The Role of Lipid Profile as an Independent Predictor of Non-alcoholic Steatosis and Steatohepatitis in Morbidly Obese Patients
by: Narges Ashraf Ganjooei, et al.
Published: (2021-05-01)

Activation and Functional Priming of Blood Neutrophils in Non-Alcoholic Fatty Liver Disease Increases in Non-Alcoholic Steatohepatitis
by: Lauszus JS, et al.
Published: (2021-11-01)

Exploration and Validation of Key Genes and Immune Infiltration in Alcoholic Hepatitis
by: Mei Y, et al.
Published: (2025-06-01)

Platelets in Alcohol-Associated Liver Disease: Interaction With NeutrophilsSummary
by: Juan Wang, et al.
Published: (2024-01-01)

SENSITIVITY AND SPECIFICITY OF VECTORCARDIOGRAPHY IN DIAGNOSTICS OF ACUTE MYOCARDIAL INFARCTION COMORBID WITH LIVER STEATOSIS AND NON-ALCOHOLIC STEATOHEPATITIS
by: I. E. Belaya, et al.
Published: (2015-12-01)

Feasibility of shear wave elastography for assessing steatosis in early-stage non-alcoholic fatty liver disease.
by: Hui Jiang, et al.
Published: (2025-01-01)

Non-invasive imaging biomarkers for liver steatosis in non-alcoholic fatty liver disease: present and future
by: Asako Nogami, et al.
Published: (2023-02-01)

Non-invasive imaging biomarkers for liver steatosis in non-alcoholic fatty liver disease: present and future
by: Lynna Alnimer, et al.
Published: (2023-04-01)

Relationship Between Non-Alcoholic Fatty Liver Disease and Degree of Hepatic Steatosis and Bone Mineral Density
by: Ruijie Xie, et al.
Published: (2022-03-01)

Ginsenoside Rb1 Alleviates Alcohol-Induced Liver Injury by Inhibiting Steatosis, Oxidative Stress, and Inflammation
by: Yuqi Lai, et al.
Published: (2021-02-01)

The ultrasound‐guided attenuation parameter is useful in quantification of hepatic steatosis in non‐alcoholic fatty liver disease
by: Yu Ogino, et al.
Published: (2021-08-01)

β-Hydroxyphosphocarnitine modifies fibrosis, steatosis and improves liver function in non-alcoholic steatohepatitis induced in rats
by: Janet Sánchez-Quevedo, et al.
Published: (2022-09-01)

Depdc5 deficiency exacerbates alcohol-induced hepatic steatosis via suppression of PPARα pathway
by: Lin Xu, et al.
Published: (2021-07-01)